Walras modulates sex-dependent endoplasmic reticulum stress in cardiomyopathy

Francisco J Martinez-Amaro1, Carlos Garcia-Padilla1,2, Fernando Bonet3,4,5

  • 1Cardiovascular Research Group, Department of Experimental Biology, University of Jaen, Jaen, Spain.

Insights

Long non-coding RNAs (lncRNAs) like Walras are implicated in cardiomyopathies. Walras exacerbates unfolded protein response (UPR) and apoptosis by degrading calumenin, worsening heart disease.

Area of Science:

  • Cardiovascular biology
  • Molecular genetics
  • Cellular stress response

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of death.
  • Cardiomyopathies often involve endoplasmic reticulum stress and the unfolded protein response (UPR).
  • The role of long non-coding RNAs (lncRNAs) in UPR and cardiomyopathies is an emerging area of research.

Purpose of the Study:

  • Investigate the role of specific lncRNAs in dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM).
  • Determine the functional impact of lncRNAs on UPR, apoptosis, and mitochondrial function.
  • Elucidate the molecular mechanism by which lncRNAs influence disease progression.

Main Methods:

  • Utilized real-time PCR (qPCR), immunochemistry (IMQ), and Western blot (WB).
  • Assessed mitochondrial activity using SeaHorse technology and performed mass spectrometry (MS).
  • Conducted cell viability assays and analyzed protein-protein interactions.

Main Results:

  • Discovered sex-dependent regulation of lncRNAs (Walar, Walaa, Wallrd, Walrad, Walras) in murine DCM and HCM models.
  • Demonstrated that Walras overexpression activates UPR, increases apoptosis, and impairs mitochondrial function.
  • Identified that Walras interacts with calumenin (CALU), promoting its proteasomal degradation, and its human homologue APO02340.1 has a similar function.

Conclusions:

  • Walras and its human homologue APO02340.1 modulate UPR-associated apoptosis via CALU protein regulation.
  • These lncRNAs act as detrimental factors in cardiomyopathies by affecting CALU protein turnover.
  • Targeting these lncRNAs could offer new therapeutic strategies for heart conditions.
Abstract

Related Concept Videos